Ischemic Stroke

Stroke is the fourth leading cause of death and leading cause of long-term disability in the United States, with the most common form being Ischemic strokes, representing about 87% of all strokes. High blood pressure, high cholesterol, smoking, obesity, and diabetes are leading causes of stroke, and 1 in 3 US adults has at least one of these conditions or habits. As neuroendovascular therapies continue to improve, many ischemic stroke patients find themselves recovering in an ICU setting. Understanding basic concepts and principles in the ischemic stroke management is a must for any intensivist, resident, or ICU rotator. 

Presentation

While overlap exits in clinical presentation between ischemic and hemorrhagic stroke patients, embolic ischemic strokes are typically sudden and maximal at onset and correspond to the affected vascular territory, while intracerebral hemorrhage typically begins with symptoms such as headache developing into worsening focal deficits over minutes to hours.


The TOAST Classification system
A system for categorization of subtypes of ischemic stroke mainly based on etiology has been developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). 



 Stroke Mimics include:


Stroke Scales

NIH Stroke Scale

Clinical grading scale used to objectively measure stroke deficits and clinical severity.  The NIHSS has been repeatedly validated with good interrater reliability as the best tool for assessing clinical stroke severity, and is an excellent way to track outcomes following medical / interventional therapies and their outcomes on ischemic stroke. 


Structure of NIHSS
The overall score is based on the aggregate of 4 factors:


Limitations do exist with use of the NIHSS, specifically in scoring strokes involving the brainstem, posterior circulation, or the severity of a right hemispheric stroke. 

NIH_Stroke_Scale.pdf

Imaging

CT Head

Broad access and low cost make the  initial imaging of choice when  evaluating a patient presenting with focal deficits concerning for stroke a non-contrasted CT Head. This allows for quick assessment of potential structural lesions or hemorrhagic strokes, both of which would be absolute contraindications to IV tPA. 

Non-contrasted CTH may also be useful for revealing signs of potential "malignant" hemispheric stroke, which would include a "hyperdense" MCA sign or MCA territory hypodensity measuring at least 1/3 of the corresponding vascular territory.





CT Angiogram
Following acquisition of a CTH, CT angiography is useful for assessing the presence or absence of a large vessel occlusion (LVO) that may be amenable mechanical thrombectomy. It can also provide useful information regarding the underlying health and structure of the patients cerebrovasculature, such as intra / extracranial atheroscelrotic disease, stenosis, or presence of a dissection. 







CT Perfusion Imaging
Perfusion imaging helps quantify the degree of ongoing ischemia and potential salvageable tissue (penumbra) present during an ischemic stroke. 

While this data is helpful, one must consider scenarios in which this information may be inaccurate. This includes patients with poor cardiac output, atrial fibrillation, severe stenosis of artery, seizure, small infarct burdens, or a poorly timed contrast bolus. CTP may also overestimate the true core infarction, especially during the acute hours of an ischemic stroke. 


3 Key parameters are involved in CT perfusion:



Note the "bright" or hyperdensity within the L MCA.
Case courtesy of Dr Bruno Di Muzio, Radiopaedia.org, rID: 28154

In the same patient as above, notice the lack of contrast filling within the artery in
question (L MCA) during acquisition of the CTA,. 

Acute Treatment

Previous AHA / ASA guidelines for treatment of ischemic stroke with thrombolytics required an NIHSS of at least 4 as the treatment threshold. However, more recent guidelines from the AHA / ASA do not completely rule out thrombolytics for patients with low (NIHSS < 4) stroke scores. Instead the decision to treat with thrombolytics should be determined on the severity of symptoms and if those symptoms are disabling to the patient. 

Basic requirements for IV thrombolytic therapy include the absence of any absolute contraindications, a systolic blood pressure < 185

Last Known Well (LKW) < 3hrsAlteplase Aka tissue plasminogen activator (tPA), is the only thrombolytic approved for use in acute ischemic stroke patients by the FDA if presenting within 3hrs of symptom onset (last known well, LKW).


Last Known Well (LKW)  between 3 hrs - 4.5 hrs 

While currently not FDA approved for use in the USA up to 4.5 hrs after symptoms onset, thrombolysis with tPA is still recommended for appropriate candidates by the AHA / ASA. The inclusion criteria are similar to the < 3hr window, but includes an exception for patients > 80 years of age, patients on warfarin with INR < 1.7, and patients with known diabetes and prior stroke.


Review of inclusion and exclusion criteria can be reviewed elsewhere in the articles for further reading section. 

Icu Management 

ICU management for acute ischemic or post intervention stroke patients involves standard ICU care with special attention to parameters such as blood pressure control, additional head imaging,  initiation of secondary stroke prevention and DVT prophylaxis. 








Management of Hemorrhage Following tPA

Within the first 24hrs of IV-tPA administration, the onset of new headache, nausea / vomiting, or worsening neurologic deficits may signal the development of intracranial hemorrhage. 

Mortality rates from tPA-related hemorrhage can be as high as 50%, so early recognition of potential signs of decline and swift action are paramount. 

Below are a list of steps to take if hemorrhage is suspected

Per MUSC protocol:



Endovascular Stroke Therapy

Mechanical thrombectomy should be a consideration for every ischemic stroke patient with a large vessel occlusion (LVO) involving the MCA, ICA, Basilar or vertebral arteries. 

Exclusion for MT include the absence of LVO or proximal LVO of CTA or large area of infarction already present on CTH imaging 

Evidence Supporting Mechanical Thrombectomy

Neuroendovascular techniques for ischemic stroke were born out of the need to expand the FDA approved 3hr treatment window for ischemic stroke and IV thrombolysis with tPA. 

2015 would usher in a new era in ischemic stroke intervention as 5 landmark trials for mechanical thrombectomy would be published and ultimately lead to this gold standard in acute ischemic stroke care.

An historical and contemporary review of endovascular therapy for acute ischemic stroke 


Degree of Revascularization:

Degree of revascularization with neuroendovascular intervention is graded with the Thrombolysis in cerebral infarction (TICI) scoring system. This scoring system is based on the  angiographic observation of blood flow immediately following the intervention.

TICI 0: no reperfusion 

TICI 1: minimal reperfusion

TICI 2a: partial filling, representing < 2/3rds of the entire vascular territory 

TICI 2b: complete refilling of the expected vascular territory but with slow filling

TICI 3: complete reperfusion

Neurosurg Focus / Volume 36 / January 2014

NSICU / NES approved BP goals post intervention:

Subarachnoid Hemorrhage: 

Thrombectomy: 

Carotid Stenting:

AVM Embolization:

Spontaneous ICH: 

Post-Op Crani:

Spinal Cord Injury


Decompressive Hemicraniectomy 

The first large data comes from 3 big trials looking at decompressive hemicraniectomies vs standard care in patients less than 60 years old with large ischemic infarcts

 
1st Generation of Trials


What about those who are older than 60 years? That's where DESTINY II comes in


Overall theme seems to be that those who are young (60 years old) do a lot better than older (> 60 years old). While it improves mortality, it doesn't necessarily improve the morbidity. When it comes to decompressive hemicraniectomy, these are what I personally think are vital to keep in mind 


Acute Ischemic Stroke

By: 

Dan K. Snelgrove MD | Assistant Professor of Neurology and Neurosurgery 

Jimmy Suh MD | Assistant Professor of Neurology and Neurosurgery

Ischemic Stroke One Pager

AIS_OnePager .pdf

Articles for Further Reading

ENLS_Acute Ischemic Stroke.pdf
Neuroimaging_in_Acute_Stroke.6.pdf
Endovascular_Treatment_of_Acute_Ischemic_Stroke.7.pdf
AHA 2019 Acute Stroke Guidelines.pdf